Take Heart in Primary Care Study

Recruiting

• Conditions: Chronic ischaemic heart disease; Comorbid depression; Cardiovascular - Other cardiovascular diseases; Mental Health - Depression

• Registration Number: ACTRN12606000371594
• Lead Sponsor: HMRC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 604

Inclusion Criteria

(GPs):All South Australian urban and urban fringe general practices,computerised, minimum of three full-time equivalent GPs, general practice nurse, offering physical space for screening.Inclusion criteria (patients):a diagnosis of ischaemic heart disease in the preceeding 6 months and requiring ongoing management for manifestations of ischaemic heart disease, particularly angina pectoris and/or heart failure, must attend the practice, speak and understand english, have intact cognitive function and be willing to provide informed consent.

Exclusion Criteria

(Patients):a psychotic illness or communication deficit precluding communication with the GP, planned correction of underlying cardiovascular disease state (eg coronary artery bypass grafting or heart transplant) or acute hospital admission for any cardiovacular reason in past 3 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of surviving patients with chronic manifestations of ischaemic heart disease who are depressed [At the completion of 12 months follow-up];A major, and related outcome, is the proportion of patients with mild versus moderate to severe depression and the proportion of initially non depressed patients who display depressive symptoms[At 12 months]

Secondary Outcome Measures

Name	Time	Method
1) Prevalence, severity and natural history of depression in a patient cohort being treated for chronic manifestations of ischaemic heart disease in primary care. [Examined at baseline, 3,6,9 and 12 months and data will be collated and assessed at the completion of 12 months. ];2) Effects of a pragmatic GP focussed screening and intervention program on the severity of depression, and effects on the overall management of chronic manifestations of ischaemic heart disease, risk factor profile, angina pectoris (AP) and heart failure (HF) specific clinical health outcomes, patient wellbeing and quality of life, treatment adherence patterns, and morbidity and mortality.[At 12 months.];3) Health related quality of life will be reassessed via the SF-12 and EQ-5D, the latter measure providing utility scores and quality adjusted life years (QALYs) for a cost utility analysis.[At 12 months followup.]